233535 Massachusetts Responds to Increasing Opioid Overdoses

Wednesday, November 10, 2010 : 10:50 AM - 11:10 AM

Alexander Walley, MD, MSc , Section of General Internal Medicine, Boston University School of Medicine and Boston Medical Center, Boston, MA
In response to a six-fold increase in annual opioid-related fatal overdoses between 1990 and 2006, the Massachusetts Department of Public Health implemented several initiatives to reduce the number of overdoses, improve the management of overdose when they occur, and diminish the diversion and misuse of prescription opioids. These efforts include an overdose education and naloxone distribution program directed at potential bystanders and first responders, supporting medication-assisted treatment in community health centers, expansion of screening, brief intervention and referral to treatment services, and funding of 15 municipalities to develop and implement community-level overdose prevention strategies. These efforts were organized and supported by the state health department, yet they were implemented through community –based institutions with established access to and relationships with high risk populations. The implementation of these policies was focused on a common goal of decreasing opioid overdose and used a set of tools that are evidence-based. It was adapted in each case to be feasible and meet the needs of the local communities. Lessons learned in implementing each of these programs will be described, along with the policy and dissemination lessons learned.

Learning Areas:
Administer health education strategies, interventions and programs
Provision of health care to the public

Learning Objectives:
To describe Massachusetts strategy to reduce opioid overdose deaths following a six –fold increase in opiod overdose fatalities To convey the State policies put in place to focus on the common goal of reducing overdose deaths by using evidenced-based tools

Presenting author's disclosure statement:

Qualified on the content I am responsible for because: I am qualified to present because I am the medical director of the Massachusetts overdose prevention pilot program and I am leading a CDC-funedd study of the impact of this program on overdose rates.
Any relevant financial relationships? No

I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.